Cairn Diagnostics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cairn Diagnostics's estimated annual revenue is currently $3.6M per year.(i)
  • Cairn Diagnostics's estimated revenue per employee is $155,000

Employee Data

  • Cairn Diagnostics has 23 Employees.(i)
  • Cairn Diagnostics grew their employee count by 5% last year.

Cairn Diagnostics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$5M3214%N/AN/A
#3
$3.6M235%N/AN/A
#4
$1.1M7-22%N/AN/A
#5
$1.7M110%N/AN/A
#6
$0.8M50%N/AN/A
#7
$6M3950%N/AN/A
#8
$0.9M60%N/AN/A
#9
$4.8M31-6%N/AN/A
#10
$1.9M120%N/AN/A
Add Company

What Is Cairn Diagnostics?

Cairn Diagnostics is a unique team of scientists, customer support professionals, and operations experts focused on creating cutting edge products and services and a world-class customer experience. Cairn makes the 13C Spirulina Gastric Emptying Breath Test (GEBT) which is a non-radioactive, non-invasive, orally administered test for measurement of the rate of solid phase gastric emptying in adults. The GEBT has been validated against the reference method of gastric scintigraphy. The GEBT utilizes the stable isotope carbon-13, denoted as 13C. The GEBT may be administered in a primary care facility, clinic or tertiary care setting

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M235%N/A
#2
$2.4M23-8%N/A
#3
$4.3M235%N/A
#4
$35M2420%N/A
#5
$4.1M24-8%N/A